98 completed, 28 unknown, 25 recruiting, 14 active not recruiting. 107 Not applicable, 9 Phase 2, 7 Phase 1, 6 Phase 4, 4 Early Phase 1.
Follow Type1diabetes: new trials by email Literature Review of Type1diabetes trials Research Report on Type1diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thrive With Type 1 Diabetes 2026 TranS-C Intervention Arm, Attention Control Enhanced Usual Care (EUC) Arm - Type1diabetes | Not applicable | Recruiting | Emory University | 48 | 2026-12-01 | 2026-11-12 |
| CGM Experience, Preferences & Blood Glucose Parameters CGM - Diabete Mellitus, Type2diabetes | Not yet recruiting | Getz Pharma | 75 | 2026-09-10 | 2026-05-26 | |
| Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D) Cherry Sports Drink - Non-Nutritive Sweetener, Type 1 Diabetes | Not applicable | Recruiting | Medical College of Wisconsin | 20 | 2026-08-05 | 2026-10-20 |
| SGLT2i, Pioglitazone, and Ketone Production in T1D Dapagliflozin 10mg Tab, Pioglitazone 15 MG and 30mg, Placebo - Type1diabetes | Phase 3 | Recruiting | The University of Texas Health Science Center at San Antonio | 24 | 2026-07-01 | 2026-07-20 |
| Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System GS3 CGM - type1diabetes, CGM | Not applicable | Recruiting | SiBionics, Co, Ltd | 36 | 2026-06-01 | 2026-08-04 |
| Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System GK5 CGKM - Type1diabetes | Not applicable | Recruiting | Henan University of Science and Technology | 12 | 2025-08-01 | 2026-08-11 |
| Tirzepatide Use in People With Obesity and Type 1 Diabetes Tirzepatide, Placebo - Type1diabetes, Obesity | Phase 4 | Recruiting | Dasman Diabetes Institute | 60 | 2025-07-31 | 2026-04-20 |
| The Effect of Therapeutic Play on Anxiety and Fear Levels in Children With Diabetes Therapeutic Play - Type1diabetes, Therapeutic Play | Not applicable | Not yet recruiting | Istanbul University - Cerrahpasa | 60 | 2025-07-18 | 2025-04-30 |
| Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System GS3 CGM - Type1diabetes | Not applicable | Recruiting | Henan University of Science and Technology | 82 | 2025-04-01 | 2026-05-29 |
| Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference MInimed 780G - Type1diabetes | Recruiting | Attikon Hospital | 240 | 2025-03-01 | 2025-11-19 | |
| Petit Cactus Study Petit Cactus - Type1diabetes | Not applicable | Completed | McGill University | 73 | 2025-02-20 | 2026-02-02 |
| Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors SGLT-2 inhibitor - Diabetes, Type1diabetes | Phase 1 | Completed | McGill University | 24 | 2024-12-05 | 2026-09-25 |
| School Readiness in Children with Type 1 Diabetes motor and sensory assessments, surveys - Type1diabetes | Not yet recruiting | arife akbulut | 78 | 2024-11-15 | 2024-11-04 | |
| 4T Sustainability Program CGM and RPM - Type1diabetes | Enrolling by invitation | Stanford University | 5000 | 2024-05-30 | 2025-05-21 | |
| Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes Insulin pump - Type1diabetes | Unknown | Oregon Health and Science University | 80 | 2024-05-15 | 2024-04-04 | |
| Accuracy of a Continuous Ketone Monitoring (CKM) System in Individuals With Type 1 Diabetes on Insulin Pump Therapy. Ketogenic diets, 8-hour insulin-suspension period - type1diabetes | Completed | McGill University | 16 | 2024-04-30 | 2025-09-26 | |
| The Effect of Omega Galil Hazelnut Chocolate Spread "O'Sweet Spread" With 80% Reduced Sucrose on Glucose Response of People With TID Omega Galil Hazelnut Chocolate Spread "O'Sweet Spread", Active Control-Nutella hazelnut cocoa spread - Type1diabetes | Not applicable | Unknown | Rabin Medical Center | 30 | 2024-03-25 | 2024-04-12 |
| First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes UP421 - Type1diabetes | Early Phase 1 | Recruiting | Per-Ola Carlsson | 2 | 2024-03-08 | 2024-12-11 |
| Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes SteadiSet Extended Wear Infusion Set - Type1diabetes | Not applicable | Completed | Tandem Diabetes Care, Inc. | 260 | 2024-03-07 | 2025-09-24 |
| The CanDo (Canadian Donor Milk) Trial Human donor milk, Formula - Small for Gestational Age at Delivery, Gestational Diabetes | Not applicable | Active not recruiting | Mount Sinai Hospital, Canada | 112 | 2024-02-06 | 2025-12-05 |
Showing 20 of 178. Sign in to see all of them.
Diabetes Mellitus, Type 1 (47) · Diabetes Mellitus (16) · Hypoglycemia (15) · Motor Activity (6) · Diabetes Complications (4) · Insulin Resistance (4) · Obesity (4) · COVID-19 (3) · Diabetes, Gestational (3) · Diabetic Nephropathies (3) · Ketosis (3) · Adolescent Behavior (2) · Anxiety Disorders (2) · Depression (2) · Diabetes Mellitus, Type 2 (2)
Nutritional and Metabolic Diseases (77) · Metabolic Diseases (74) · Glucose Metabolism Disorders (71) · Endocrine System Diseases (62) · Immune System Diseases (49) · Autoimmune Diseases (47) · Diabetes Mellitus (46) · Behavior (13) · Pathological Conditions, Signs and Symptoms (8) · Female Urogenital Diseases and Pregnancy Complications (7) · Urogenital Diseases (7) · Hyperinsulinism (5) · Mental Disorders (5) · Signs and Symptoms (5) · Body Weight (4)
Blood Specimen Collection (3) · Drug Delivery Systems (3) · Insulin (3) · dapagliflozin (3) · empagliflozin (3) · Continuous Glucose Monitoring (2) · Exercise (2) · Glucagon (2) · Glucagon-Like Peptide 1 (2) · High-Intensity Interval Training (2) · Magnetic Resonance Spectroscopy (2) · Motivational Interviewing (2) · Sodium Chloride (2) · Standard of Care (2) · Surveys and Questionnaires (2)
Medical College of Wisconsin (7) · Liverpool John Moores University (5) · McGill University (5) · University of Colorado, Denver (5) · Yale University (5) · Rabin Medical Center (4) · Steno Diabetes Center Copenhagen (4) · Boston Children's Hospital (3) · Stanford University (3) · Assistance Publique - Hôpitaux de Paris (2) · Central Hospital, Nancy, France (2) · Dasman Diabetes Institute (2) · Emory University (2) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (2) · Henan University of Science and Technology (2)
United States (55) · Canada (15) · France (15) · Denmark (12) · Sweden (9) · United Kingdom (8) · China (7) · Israel (7) · Turkey (Türkiye) (6) · Italy (4) · Spain (4) · Belgium (3) · Czechia (2) · Egypt (2) · Finland (2)
Anne-Sophie Brazeau, PhD (2) · David M Maahs, MD, PhD (2) · Hongwei Jiang (2) · Michael Tsoukas, M.D. (2) · Pamela Martyn-Nemeth, PhD (2) · Per-Ola Carlsson, MD, PhD (2) · Adrian Vella, MD (1) · Ahmad Haidar, Ph.D. (1) · Alayne Lehman, RN, MS (1) · Aleksandr Peet (1) · Alexandros Kokkinos (1) · Alfred Penfornis (1) · Anastasia Albanese-O'Neill, PhD (1)
PMID 18948167, PMID 18971433, PMID 19333547, PMID 19573115, PMID 21355715, PMID 25271602, PMID 25271603, PMID 25316271, PMID 26073672, PMID 26453955, PMID 27510442, PMID 27841330, PMID 28273644, PMID 29151123, PMID 29230878, PMID 29361766, PMID 30186878, PMID 30252054, PMID 30281094, PMID 30449209, PMID 31082869, PMID 31335171, PMID 31375042, PMID 31408136, PMID 31481560, PMID 31530659, PMID 31530660, PMID 31719096, PMID 31766999, PMID 32180188, PMID 32240944, PMID 32295804, PMID 32667835, PMID 32907828, PMID 33362714, PMID 33628834, PMID 34047700, PMID 34809482, PMID 35321886, PMID 35417272, PMID 35568602, PMID 35994729, PMID 36364803, PMID 36482870, PMID 36761922, PMID 36793089, PMID 36824050, PMID 37074715, PMID 37335759, PMID 37418844
R01DK091331 (2), 1DP3DK108211-01 (1), 2016 (1), 2018 (1), 2019 (1), 2023 (1), P30DK092949 (1), R01DK024092 (1), R01DK122564 (1), R01DK128236 (1), R01DK134398 (1), R01DK136604 (1), R18DK122422 (1), R34AT011035 (1)